The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...
Hosted on MSN3mon
A needleless alternative to the EpiPen is now widely availableHUNTSVILLE, Ala. (WAFF) - There is now an FDA-approved alternative to the EpiPen. A new nasal spray, called Neffy, can be used by people to treat severe allergic reactions. The new spray has ...
“There are a few things that can interfere with the effectiveness of an EpiPen,” Dr. Travis Stork, an ER physician, host of The Doctors and a member of PEOPLE’s Health Squad, says. The first ...
Green Matters on MSN7mon
Neffy, the Needle-Free Alternative to EpiPen, Earns FDA Approval — Here's What It Will Cost YouEpiPen users can expect to see Neffy hitting the shelves about eight weeks after it was approved, so sometime in early ...
Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...
The proposed settlement would end an ongoing lawsuit against Viatris Inc. (formerly Mylan), the makers of EpiPen, that began in 2016 after public outrage over the company's decision to raise the ...
SEE ALSO: How social media amplified anger over EpiPen's price gouge In a blog post on his company's website, Saunders didn't directly name Mylan, but said he condemns dramatic price increases in ...
Sanofi claims its Auvi-Q, a more portable epinephrine autoinjector with a retractable needle and audio instructions, couldn't compete on the unlevel playing field Mylan created for its EpiPen. (CN) — ...
San Diego-based ARS Pharmaceuticals received the green light from health regulators for a needle-free alternative to the EpiPen for children as young as 4 years old. The U.S. Food and Drug ...
You'd think one scandal would be enough. Mylan, the company that came under fire this summer for systematically raising the price of the EpiPen, is caught up in another drug price scheme.
San Diego-based ARS Pharmaceuticals received the green light from health regulators for a needle-free alternative to the EpiPen for children as young as 4 years old. The U.S. Food and Drug ...
At first, I tried to bring about a socialist paradise by reducing the price of the EpiPen to $0. This meant I was bringing in no money and my investors were none too pleased. That approach went ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback